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Abstract
Introduction Nonoperative management (NOM) has
become the treatment of choice for hemodynamically sta-
ble patients with blunt splenic injury. Results of outcome
after NOM are predominantly based on large-volume
studies from level 1 trauma centers in the United States.
This study was designed to assess the results of NOM in a
relatively low-volume Dutch level 1 trauma center.
Methods An analysis of a prospective trauma registry was
performed for a 6-year period before (period 1) and after
the introduction and implementation of splenic artery
embolization (SAE) (period 2). Primary outcome was the
failure rate of initial treatment.
Results A total of 151 patients were reviewed. An
increased use of SAE and a reduction of splenic operations
during the second period was observed. Compared with
period 1, the failure rate after observation in period 2
decreased from 25% to 10%. The failure rate after SAE in
period 2 was 18%. The splenic salvage rate (SSR) after
observation increased from 79% in the ﬁrst period to 100%
in the second period. During the second period, all patients
with failure after observation were successfully treated
with SAE. The SSR after SAE in periods 1 and 2 was
respectively 100% and 86%.
Conclusions SAE of patients with blunt splenic injuries is
associated with a reduction in splenic operations. The
failure and splenic salvage rates in this current study were
comparable with the results from large-volume studies of
level 1 trauma centers. Nonoperative management also is
feasible in a relatively low-volume level 1 trauma center
outside the United States.
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Introduction
Trauma is one of the leading causes of death in people
younger than age 40 years and, therefore, is an important
problem in general healthcare [1–3]. The spleen is affected
in 32% of patients with traumatic abdominal injuries [4].
Management of splenic injuries has changed consider-
ably during the past 20 years. Traditionally, a laparotomy
and splenectomy was performed for splenic injuries. Due to
its high success rate, nonoperative management (NOM) has
evolved to be the standard of care in hemodynamically
stable patients.
NOM can be divided in observation or splenic artery
embolization (SAE). SAE has played an increasing role in
this nonoperative approach. Many reviews supported the
use of SAE as an adjunct to observation. SAE can increase
the success rate of NOM by stopping ongoing bleeding and
by preventing delayed rupture of the spleen. Recent studies
advocate the use of angiography and embolization in the
presence of the following CT ﬁndings: contrast extrava-
sation, pseudoaneurysm or arteriovenous ﬁstula, large
hemoperitoneum, and a high grade of injury (grade III–V)
[5–15]. Results of outcome after NOM in blunt splenic
C. H. van der Vlies (&)  J. Hoekstra  K. J. Ponsen 
J. C. Goslings
Trauma Unit, Department of Surgery, Academic Medical Center,
Meibergdreef 9, 1105 Amsterdam, The Netherlands
e-mail: c.h.vandervlies@amc.uva.nl
J. A. Reekers  O. M. van Delden
Department of Radiology, Academic Medical Center,
Amsterdam, The Netherlands
123
Cardiovasc Intervent Radiol (2012) 35:76–81
DOI 10.1007/s00270-011-0132-ztrauma are predominantly based on large-volume studies
from level 1 trauma centers in the United States [5–9, 13,
16, 17]. Trauma patient volumes in European centers often
are considerably lower than in the United States. Therefore,
it is questionable whether these results can be translated to
centers with lower volumes of patients with blunt splenic
injuries. The purpose of this study was to assess the
inﬂuence of SAE on the failure of NOM and the splenic
salvage rate in a relatively low-volume level 1 Dutch
trauma center.
Methods
Data Collection
Patients with blunt splenic injuries treated in the Academic
Medical Center (AMC) between January 1997 and June
2008 were identiﬁed from the prospectively collected data
in the hospital’s trauma registry. Children younger than age
17 years and patients who died within 24 h after trauma
were excluded. The AMC is a designated Dutch level 1
trauma center with 32,000 emergency department visits
and 700 trauma team notiﬁcations per year. Annually,
approximately 200–225 multitrauma patients are treated.
Patient demographics, including age, gender, trauma
mechanism, Injury Severity Score (ISS), Glasgow Coma
Scale (GCS), and associated injuries, were extracted from
the computerized medical record. Furthermore, initial
treatment and their indications, transfusion requirements,
morbidity, mortality, and intensive care unit and overall
hospital length of stay were registered.
One senior trauma radiologist reevaluated all admission
abdominal CT scans and classiﬁed the splenic injuries
according to the American Association for the Surgery of
Trauma (AAST) [18]. Grades I and II were classiﬁed as
low grade and grades III–V as high grade. Data on the
presence of vascular injury (contrast extravasation, pseu-
doaneurysm, and arteriovenous ﬁstula), hemoperitoneum,
and the extension of hemoperitoneum also were registered.
Minimal hemoperitoneum was deﬁned as intra-abdominal
blood located only in the perisplenic recess. Signiﬁcant
hemoperitoneum was deﬁned as intra-abdominal blood
located in areas other than the perisplenic recess.
Study Periods
Two time periods were deﬁned. At the end of the ﬁrst
period (1997–2002), angiography and embolization for
trauma patients was introduced but not used routinely. This
period was compared with a second period (2003–2008)
when SAE was used routinely.
Imaging and Treatment Protocols
During both periods, hemodynamically unstable patients
who were not responding to ﬂuid resuscitation were treated
primarily operatively. During period 1, the protocol dic-
tated surgical exploration in patients with high-grade
injuries (grades 3–4), independent of the hemodynamic
status of the patients. Operative treatment began with four-
quadrant packing before structural inspection of the abdo-
men. Once the spleen has been mobilized, a decision was
made whether a splenectomy or a splenic salvage proce-
dure (mesh splenorrhaphy, partial resection, adhesive, and/
or coagulation techniques) was performed.
During period 1, NOM was performed in patients with
low-grade (grades 1–2) injuries who were hemodynami-
cally stable. During period 2, NOM was performed in all
hemodynamically stable patients or transient responders.
NOM involves admission to a unit with monitoring of vital
signs, strict bed rest, frequent monitoring of red blood cell
count, and serial abdominal examinations. During the
second period, SAE was routinely performed 24 h/7 days
per week by an experienced interventional radiologist if
signs of active bleeding (contrast blush or cutoff), pseu-
doaneurysm, or arteriovenous ﬁstula were detected on CT
scan. Splenic arterial catheterization was performed by
using the common femoral artery access. After puncture of
the artery a 5-Fr sheath was introduced.
Diagnostic series of the splenic artery were obtained
using a 4- or 5-Fr catheter or celiac catheter. For selective
catheterization of splenic artery branches coaxial micro-
catheters and microguidewires were required.
Proximal embolization was performed if there was a
diffuse bleeding of the spleen, if there were multiple focal
bleeding vessels in the spleen, when there was time-pres-
sure as a result of the hemodynamic situation of the patient,
or when tortuosity of the splenic artery prevented selective
distal embolization. Selective distal embolization was
reserved for patients who had one or only a few focal
bleeding vessels in the spleen and in whom the anatomy
and hemodynamic situation allowed employment of this.
Follow-up ultrasounds or CT scans were not routinely
performed.
Study Endpoints
Primary outcome was the failure rate of initial treatment.
Failure was deﬁned as clinical (hemodynamically unstable
or drop in hemoglobin/hematocrit) and radiological (a
blush or signiﬁcant increase of hemoperitoneum on repeat
CT scan) signs of a rebleeding requiring operative or
radiological (re-)interventions. The failure rate and the
splenic salvage rate in both periods were compared to
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as patient discharge with the spleen in situ.
Secondary outcome measures were length of intensive
care unit and total hospital stay, transfusion requirements
during the ﬁrst 24 h, and mortality rate. Mortality was
coded as due to splenic injury complications or other
causes.
Statistical Analysis
All statistical analyses were performed by using SPSS
version 17 (SPSS, Inc., Chicago, IL). Categorical variables
were calculated as percentages and compared by using Chi-
square analyses or Fisher’s exact tests when appropriate.
All continuous variables are presented as median with
interquartile ranges (p25–p75) and were compared by using
the Mann–Whitney U test. A value of P = 0.05 was con-
sidered statistically signiﬁcant.
Results
A total of 151 patients with blunt splenic injury were
identiﬁed. Twenty-nine patients were excluded: 6 patients
died within 24 h of admission and 23 patients were chil-
dren. Of the 122 included patients, the majority were young
men with a mean age of 29 (range, 23–46) years. As
demonstrated in Table 1, both periods were comparable for
age, gender, and ISS and AAST injury grade.
In Table 1, the initial treatment is shown for both peri-
ods. The number of patients treated with observation was
similar. During period 2, a signiﬁcant increase of SAEs
was observed: 4% during the ﬁrst period versus 34% during
the second period (P\0.001). This increase correlated
with the statistically signiﬁcant reduction of splenic oper-
ations (46% vs. 19%; P\0.001).
Most of the patients who underwent SAE (13/24) did so
as initial treatment. In 10% of the patients, injuries to other
organs were embolized during the same angiography ses-
sion. Table 2 shows the failure rate after initial treatment in
both periods. The overall failure rate for observation and
SAE was both 17%. During the second period, the failure
rate after observation was reduced from 25% to 10%. The
failure rate after SAE in period 2 was 18%; SAE failed in 4
of the 22 patients due to rebleeding of the spleen.
Table 3 shows the injuries divided into low and high
AAST grades per period and compared for primary treat-
ment and outcomes. Most of the patients who failed initial
treatment had high grade of injury. Twenty-ﬁve percent of
the patients with high-grade injury failed initial SAE,
whereas no failure of SAE was observed in patients with
low-grade injury. The characteristics of the patients with
failure of initial treatment are depicted in Table 4.I n
almost all of these patients, the reevaluated CT scan
showed a contrast blush and/or a signiﬁcant hemoperito-
neum. Three of the four patients who failed SAE during the
second period had a grade 5 injury combined with a blush
and a signiﬁcant hemoperitoneum on the CT scan.
The overall splenic salvage rate was 89%. Compared
with period 1, the SSR after observation in period 2
increased from 79% to 100%. During the ﬁrst period, six of
the seven patients who failed observation underwent a
splenectomy. In one patient, splenic-preserving therapy
during laparotomy was performed. In the second period, all
patients with failure (n = 3) after observation were suc-
cessfully treated with SAE.
The splenic salvage rate after SAE in periods 1 and 2
was respectively 100% and 86%. One of the four patients
Table 1 Characteristics, treatment, and outcomes of patients with
blunt splenic injuries
Period 1 Period 2 P
Characteristics
N 56 66 NS
Age, yr (range) 28 (23–38) 34 (23–51) NS
Male 66% 77% NS
ISS 25 (13–36) 24 (16–36) NS
AAST injury grade
Low (I–II) 46% 53% NS
High (III–V) 54% 47%
Treatment
Observation n (%) 28 (50) 31 (47) NS
SAE n (%) 2 (4) 22 (34) \0.001*
Splenic surgery n (%) 26 (46) 13 (19) \0.001*
Splenectomy 22 7
Splenorrhaphy 3 4
Other 1 2
Outcomes
Mortality n (%)
Overall 8 (14%) 5 (8%) NS
Spleen-related 5 (9%) 2 (3%) NS
Length of stay (range) 11 (4–26) 13 (6–25) NS
ICU stay (range) 2 (1–8) 2 (1–3) NS
PRBC\24 h (range) 11 (4–26) 0 (0–4) 0.01*
SAE splenic artery embolization, ICU intensive care unit,
PRBC packed red blood cells, NS not signiﬁcant
* Statistically signiﬁcant
Table 2 Failure rate of primary treatment
Overall
%( n)
Period 1
%( n)
Period 2
%( n)
P
Observation 17 (10/59) 25 (7/28) 10 (3/31) 0.07
Splenic artery embolization 17 (4/24) 0 (0/2) 18 (4/22) –
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underwent proximal reembolization during the second
period. The other three patients underwent a splenectomy.
The median time from initial treatment to failure was 2
(range, 1–23) days. In two patients, the rebleeding occurred
after being discharged from hospital. One patient with a
grade 5 splenic injury, initially treated with embolization,
had severe neurological impairment due to rebleeding and
died 3 months later.
The mortality rate and intensive care unit and total
length of stay were not different for both periods. The
transfusion requirement was signiﬁcantly (P\0.01) lower
during the second period (Table 1) in both nonoperative
management and operative treatment.
Discussion
The primary outcome of this study was to assess the
inﬂuence of SAE on the failure and splenic salvage rate.
Consistent with the literature, we showed a change from
operative to nonoperative management for patients with
blunt splenic injury. The ﬁrst successful use of SAE for a
splenic injury was described by Sclafani et al [19]. In our
level 1 trauma center, SAE was introduced in 1998 and
since 2002 has been used routinely for hemodynamically
stable patients who are considered to be at high risk of
failure. In the ﬁrst period we evaluated, a splenic operation
was performed in almost half of the patients. In the second
period, the rate of splenic operations was reduced, whereas
the use of SAE increased over time.
In this study, the failure rate after observation was
reduced in the second period. More frequent use of CT scan
and the improvement of the quality of the CT scan could be
an explanation for the clear trend of decreasing failure rate
after observation in the second period. This improved CT
technique may enable better patient selection for observa-
tion or SAE.
We reported a failure rate of 18% after SAE in the
second period. It is not fair to compare the failure rates of
SAE between the two periods because only two patients in
the ﬁrst period were treated with SAE. This reported failure
rate is comparable with the results of a large, multicenter
trial in which splenic embolization was used in 140
patients. This study reported an overall splenic salvage rate
of 87% and 83% for grade 4 and 5 injuries, which were
successfully managed with embolization [7].
All patients who failed initial SAE had a high grade of
injury. Strikingly, in our study three of the four patients
who failed SAE in the second period had a grade 5 injury
combined with a vascular blush and a signiﬁcant hemo-
peritoneum on the CT scan, suggesting that the optimal
patient selection for SAE is still a topic for further research.
Some authors recommend a low threshold to operate if
there is evidence of a grade 3–5 injury combined with a
signiﬁcant hemoperitoneum [13, 20]. Furthermore, with
respect to this fact one patient who failed SAE became
hemodynamically unstable due to rebleeding and conse-
quently developed severe neurological damage and died
3 months later.
Failure was observed after proximal as well as distal
selective embolization (Table 4). The current literature
provides little evidence of whether proximal SAE or distal
selective embolization is a better treatment. Although no
prospective studies that compare the results of proximal or
Table 3 Outcomes per period for low- and high-grade injuries
Period Grade (n) Treatment (n) Rebleeding n (%)
1 Low (26) Observation (19) 4 (21)
Laparotomy (7) 0
High (30) Observation (9) 3 (33)
SAE (2) 0
Laparotomy (19) 0
2 Low (35) Observation (22) 1 (5)
SAE (6) 0
Laparotomy (7) 0
High (31) Observation (9) 2 (22)
SAE (16) 4 (25)
Laparotomy (6) 0
Grade: according to the American Association for the Surgery of
Trauma (AAST)
Table 4 Characteristics of patients with failure of initial treatment
No. Period ISS Treatment Grade CT Blush Hemoperitoneum
1 1 16 Observation 1 Yes No Minimal
2 1 8 Observation 1 No – –
3 1 22 Observation 1 Yes No Minimal
4 1 24 Observation 1 No – –
5 1 36 Observation 3 No – –
6 1 13 Observation 3 No – –
7 1 36 Observation 4 Yes No Signiﬁcant
8 2 16 Proximal
SAE
3 Yes Yes Signiﬁcant
9 2 16 Observation 3 Yes No Signiﬁcant
10 2 41 Observation 3 Yes Yes Signiﬁcant
11 2 29 Observation 2 Yes Yes Minimal
12 2 25 Proximal
SAE
5 Yes Yes Signiﬁcant
13 2 41 Distal SAE 5 Yes Yes Signiﬁcant
14 2 41 Distal SAE 5 Yes Yes Signiﬁcant
ISS Injury Severity Score, SAE splenic artery embolization, Grade
according to the American Association for the Surgery of Trauma
(AAST), AVF arteriovenous ﬁstula, PA pseudoaneurysm
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SAE seems to be faster, associated with a lower failure rate
of NOM, and a decreased incidence of splenic abscess or
infarction [13, 21, 22]. A disadvantage of proximal SAE
could be the fact that in case of rebleeding, more selective
embolization is difﬁcult due to the inaccessibility of the
splenic artery.
The overall splenic savage rate was 89%. During period
2, the SSR after observation was increased, due to the
successful secondary treatment with SAE of patients who
failed initial treatment. In the SAE group, one patient with
rebleeding could successfully be treated with subsequent
proximal embolization. Despite rebleeding, SAE is a
valuable minimally invasive technique to control bleeding.
Historically, every patient with rebleeding was treated
surgically. Currently, a second attempt of SAE can be
considered, which further can increase the nonoperative
splenic salvage rate [5, 7, 16].
Results of outcome after NOM in blunt splenic trauma
are predominantly based on large-volume studies from
level 1 trauma centers in the United States. Despite the
lower patient volume in this study, the failure rate and SSR
are comparable with the results of these large studies. In
these studies, the SSR of nonoperative management with
the use of splenic embolization ranges from 86% to 100%,
with most studies reporting success rates [90% [5–9, 13,
16, 17].
The second goal of this study was to assess the effects
on clinical outcome. More frequent use of SAE and con-
sequently lesser laparotomies have the theoretical potential
of decreasing length of hospital stay and blood transfusion
requirements. However, in this study the ICU and total
length of stay were comparable in both periods. The
transfusion requirement was signiﬁcantly lower in the
second period. The more frequent use of SAE could not
alone explain the lower transfusion rate, whereas patients
with operative treatment also received fewer transfusions
during period 2. Part of the explanation possibly could be
the advancements in the areas of critical care and trans-
fusion and resuscitation policies.
As with any retrospective study, our analysis has several
limitations. Selection bias might have played a role.
Despite protocols for diagnostics and treatment, in practice
the choice of therapy was based on the clinical judgement
of the attending trauma surgeon and (interventional) radi-
ologist. The speciﬁc indication for the chosen therapy
could not always be assessed from the trauma registry or
electronic medical record. Furthermore, advancements in
ICU treatment, transfusion protocols, improved quality of
the CT scan, and SAE between the two time periods
investigated could cause a bias in the results. This study did
not evaluate isolated splenic trauma as in most of the pub-
lished series. As a consequence, the mortality, morbidity,
and transfusion requirement could reﬂect variability in
recruitment, which is observed most modern countries
(decrease number of severe road accidents during the last
15 years). Another limitation is the relatively small number
of patients with blunt splenic injury in our hospital. This
volume, however, is comparable to other level 1 trauma
centers in Europe.
In conclusion, the increased use of SAE as an adjunct to
NOM was associated with a statistically signiﬁcant reduc-
tion of splenic operations.
The failure and splenic salvage rates in the current study
were comparable with the results from large-volume studies
of level 1 trauma centers in the United States. Comparable
with the literature, a high failure rate was observed in
patients with high-grade injuries combined with a contrast
blush and a signiﬁcant hemoperitoneum. Therefore, NOM
with the adjunction of SAE in patients with low-grade
injuries is feasible in a relatively low-volume level 1 trauma
center outside the United States. However, the optimal
treatment, especially in patients with high-grade injuries, is
still a topic for further research.
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